Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 69 (*RPL21P69*) is a processed pseudogene found on human chromosome 6q25.3. It is derived from the ribosomal protein L21 (*RPL21*) gene, which encodes a structural protein of the large 60S ribosomal subunit used in protein synthesis. Pseudogenes like *RPL21P69* are genomic sequences with high similarity to functional genes but do not encode functional proteins due to disabling mutations or sequence interruptions. Such pseudogenes are common for ribosomal protein genes, reflecting their evolutionary history and retrotransposition mechanisms, but they lack established roles in cellular biology or disease. *RPL21P69* is not considered a therapeutic target nor an active biomolecule in any known pathway. If you seek information on the functional ribosomal protein, refer to **Ribosomal protein L21 (RPL21)** rather than the pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 69 (RPL21P69).